An EU pharmaceutical licensed company, MGC Pharmaceuticals Ltd (ASX: MXC) is an industry-leading, European biopharma company supplying GMP Phytocannabinoid derived medicines to patients globally.

With many years of real-world, technical and professional experience, MGC Pharma’s founders are all celebrated trailblazers in the Phytocannabinoid industry. MGC Pharma’s main objective is to create and supply superb Cannabinoid based pharmaceutical products for medical markets in North America, Europe, and Australasia.